期刊文献+

神经肽FF的生物活性研究进展 被引量:2

Advances in the Biological Activity of Neuropeptide FF
原文传递
导出
摘要 神经肽FF(neuropeptide FF,NPFF)最初于1985年从牛脑中分离得到,是一种哺乳动物体内普遍存在的八肽。NPFF最早因具有调节阿片镇痛活性而引起关注,而后陆续发现NPFF具有多种生理功能,包括调节体温、心血管、神经内分泌、胃肠运动、摄食、抗炎、免疫调节、以及神经保护等。现在认为NPFF是一种具有激素样活性的神经递质,因此对其生理功能的深入研究有助于理解NPFF在多种生理系统中的作用机制及其潜在多肽药物的研发。本文综述了近年来NPFF生物活性的最新研究进展,结合本实验室已有研究基础,重点介绍了NPFF在神经内分泌、免疫调节、抗炎、神经保护、及信号通路方面的进展,并展望了NPFF类多肽药物今后的发展方向。 Neuropeptide FF (NPFF) was originally isolated from bovine brain in 1985. As an octapeptide, NPFF distributes ubiq- uitously among mammals. NPFF was initially recognized as an opioid-modulating peptide for its action in regulating opioid analgesic ac- tivity, however, later studies show that NPFF has important roles in regulating multiple biological processes, such as body temperature, cardiovascular, neuroendocrine, gastrointestinal motility, feeding, anti-inflammation, immunomodulation, and neuroprotection. Currently, NPFF is considered as a hormone-like neurotransmitter. Hence, a comprehensive understanding on NPFF bioactivity will be helpful for not only the mechanism of NPFF in multiple physical roles but also the potential peptide drug development. In this paper, the latest ad- vances in NPFF bioactivity are reviewed, especially its fimctions in neuroendocrine, immune regulation, anti-inflammatory, and neuro- protective. Moreover, the research trends for the future are prospected.
出处 《现代生物医学进展》 CAS 2015年第7期1365-1368,共4页 Progress in Modern Biomedicine
基金 国家自然科学基金项目(81401553) 中国博士后科学基金项目(2014M552492) 中央高校基本科研业务费科研资助项目(3102014JKY15010) 国家重点基础发展规划项目(973项目)(2011CB710903) 陕西省博士后科研资助项目
关键词 神经肽 NPFF NPFF受体 RF9 免疫调节 Neuropeptide NPFF NPFF receptor RF9 Immunomodulation
  • 相关文献

参考文献52

  • 1Chanut-Delalande H, Hashimoto Y, Pelissier-Monier A, et al. Pri pep- tides are mediators of ecdysone for the temporal control of develop- ment[J]. Nat Cell Biol, 2014, 16(11): 1035-1044.
  • 2MiUar RP, Newton CL. Current and future applications of GnRH, kisspeptin and neurokinin B analogues[J]. Nat Rev Endocrinol, 2013, 9(8): 451-466.
  • 3Yang HY, Fratta W, Majane EA, et al. Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine[J]. Proc Natl Acad Sci U S A, 1985, 82(22): 7757-7761.
  • 4Bonini JA, Jones KA, Adham N, et al. Identification and characteriza- tion of two G protein-coupled receptors for neuropeptide FF[J]. J Biol Chem, 2000, 275(50): 39324-39331.
  • 5Liu Q, Guan XM, Martin WJ, et al. Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception [J]. J Biol Chem, 2001, 276(40): 36961-36969.
  • 6Gouarderes C, Quelven I, Mollereau C, et al. Quantitative autoradio- graphic distribution of NPFF1 neuropeptide FF receptor in the rat brain and comparison with NPFF2 receptor by using [125I]YVP and [ (125I]EYF as selective radioligands [J]. Neuroscience, 2002, 115(2): 349-361.
  • 7Zeng Z, McDonald TP, Wang R, et al. Neuropeptide FF receptor 2 (NPFF2) is localized to pain-processing regions in the primate spinal cord and the lower level of the medulla oblongata [J]. J Chem Neuroanat, 2003, 25(4): 269-278.
  • 8Goncharuk V, Zeng Z, Wang R, et al. Distribution of the neuropep- tide FF1 receptor (hFF 1) in the human hypothalamus and surrounding basal forebrain structures: immunohistochemical study [J]. J Comp Neurol, 2004, 474(4): 487-503.
  • 9Sundblom DM, Heikman P, Naukkarinen H, et al. Blood concentra- tions of vasopressin, neuropeptide FF and prolactin are increased by high-dose right unilateral ECT[J]. Peptides, 1999, 20(3): 319-326.
  • 10Ayachi S, Simonin F. Involvement of Mammalian RF-Amide Peptides and Their Receptors in the Modulation of Nociception in Rodents [J]. Frontiers in endocrinology, 2014, 5:158.

二级参考文献156

  • 1Lake J R, Hebert K M, Payza K, et al. Neurosci. Lett., 1992, 146:203-206
  • 2Malin D H, Lake J R, Leyva J E, et al. Peptides, 1991, 12: 1011-1014
  • 3Prokai L, Prokai-Tatrai K, Zharikova A, et al. J. Med. Chem., 2001, 44:1623-1626
  • 4Yu Y, Shao X, Cui Y, et al. ChemMedChem, 2007, 2: 309- 317
  • 5Liu H M, Zhang B Z, Liu X F, et al. Bioorg. Med. Chem., 2007, 15:1694-1702
  • 6Liu H M, Liu X F, Yao J L, et al. J. Pharmacol. Exp. Ther., 2006, 319:308-316
  • 7Gao Y, Liu X, Liu W, et al. Bioorg. Med. Chem. Lett., 2006, 16:3688-3692
  • 8Yu Y, Wang C L, Cui Y, et al. Peptides, 2006, 27:136-143
  • 9Wei J, Shao X, Gong M Z, et al. Bioorg. Med. Chem. Lett., 2005, 15 : 2986-2989
  • 10Gao Y F, Liu X, Wei J, et al. Bioorg. Med. Chem. Lett., 2005, 15:1847-1850

共引文献7

同被引文献16

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部